Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05858632
PHASE4

Immune Spatial Features of Guselkumab Cutaneous Response

Sponsor: University of California, San Francisco

View on ClinicalTrials.gov

Summary

This study examines the effect of IL-23 blockade with Guselkumab on the immune cells of scalp psoriasis lesions.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2023-07-01

Completion Date

2026-06-30

Last Updated

2023-08-28

Healthy Volunteers

Yes

Interventions

DRUG

Guselkumab

Guselkumab treatment for \~ 9 months

Locations (1)

University of California San Francisco

San Francisco, California, United States